Drug responsiveness of leukemic cells detected in vitro at diagnosis correlates with therapy response and survival in patients with acute myeloid leukemia.
Maria A KolesnikovaAleksandra V Sen'kovaTatiana I PospelovaMarina A ZenkovaPublished in: Cancer reports (Hoboken, N.J.) (2021)
The evaluation of the responsiveness of tumor cells to chemotherapy in vitro at diagnosis can be a useful tool for predicting the response of leukemia patients to planned chemotherapy.
Keyphrases
- acute myeloid leukemia
- end stage renal disease
- newly diagnosed
- induced apoptosis
- chronic kidney disease
- ejection fraction
- locally advanced
- prognostic factors
- allogeneic hematopoietic stem cell transplantation
- peritoneal dialysis
- bone marrow
- cell cycle arrest
- squamous cell carcinoma
- emergency department
- patient reported outcomes
- endoplasmic reticulum stress
- cell death
- chemotherapy induced
- smoking cessation
- adverse drug